醫療季營收分析

最後更新 2025-12-06 08:38:07 (UTC+8)

季營收趨勢分析

醫療類股公司整體季營收成長趨勢。

醫療類股調整後季營收與 XLV ETF走勢圖

FindBillion.com

季節調整後季營收成長率


季營收季增率	4.7%
季營收年增率	10.7%

季營收與股價相關性分析

判斷醫療類股ETF(XLV) 股價和醫療類股整體季節調整後季營收有無相關性，若中高度相關性，可由整體季節調整後季營收推估股價是否合理。

醫療類股整體季節調整後季營收-股價散佈圖

醫療類股整體季節調整後季營收與股價高度相關，相關性越高，參考意義越大。

醫療類股整體季節調整後季營收與股價間的
決定係數

高度相關 0.87

FindBillion.com

📢

廣告載入中...

相關個股

醫療相關的個股，以及該個股的季營收季增率、年增率。

代碼	公司名稱	季營收季增率	季營收年增率
MRNA	Moderna, Inc.	300.2%	-45.2%
BNTX	BioNTech SE	261.5%	22%
RNA	Avidity Biosciences, Inc.	216%	434%
RDY	Dr. Reddy's Laboratories Limited	123.3%	9.8%
ROIV	Roivant Sciences Ltd.	87.8%	-64.9%
MOH	Molina Healthcare, Inc.	84.8%	103%
ARGX	argenx SE	79.8%	5.1%
ALNY	Alnylam Pharmaceuticals, Inc.	73.9%	149.3%
HLN	Haleon plc	43.4%	-3.8%
MRUS	Merus N.V.	42.7%	-1.9%
INSM	Insmed Incorporated	32.3%	52.4%
CAI	Caris Life Sciences, Inc.	31.5%	168.8%
RYTM	Rhythm Pharmaceuticals, Inc.	28.1%	54.3%
MDGL	Madrigal Pharmaceuticals, Inc.	26.8%	362%
BBIO	BridgeBio Pharma, Inc.	25.3%	4318%
PTCT	PTC Therapeutics, Inc.	22%	7.2%
GH	Guardant Health, Inc.	17.3%	38.5%
INCY	Incyte Corporation	15.7%	20%
LLY	Eli Lilly and Company	14.7%	53.9%
AXSM	Axsome Therapeutics, Inc.	14.6%	63.2%
DOCS	Doximity, Inc.	11.9%	23.2%
RGEN	Repligen Corporation	9.9%	21.9%
PFE	Pfizer Inc.	9.6%	-5.9%
MEDP	Medpace Holdings, Inc.	9.1%	23.7%
WST	West Pharmaceutical Services, Inc.	8.7%	7.7%
JAZZ	Jazz Pharmaceuticals plc	8.5%	6.7%
NTRA	Natera, Inc.	8.3%	34.7%
CI	Cigna Corporation	8.2%	9.5%
DHR	Danaher Corporation	8.2%	4.4%
CAH	Cardinal Health, Inc.	7.6%	22.4%
HIMS	Hims & Hers Health, Inc.	6.7%	49.2%
TAK	Takeda Pharmaceutical Company Limited	6.7%	-5.4%
CORT	Corcept Therapeutics Incorporated	6.6%	13.7%
UHS	Universal Health Services, Inc.	6.4%	13.4%
TEVA	Teva Pharmaceutical Industries Limited	6.3%	3.4%
SNY	Sanofi	6.3%	-7%
VRTX	Vertex Pharmaceuticals Incorporated	6.2%	11%
ASND	Ascendis Pharma A/S	5.9%	269.4%
EXEL	Exelixis, Inc.	5.1%	10.8%
AMGN	Amgen Inc.	5.1%	12.4%
REGN	Regeneron Pharmaceuticals, Inc.	4.8%	0.9%
RMD	ResMed Inc.	4.7%	9.1%
ENSG	The Ensign Group, Inc.	4.6%	19.8%
WAT	Waters Corporation	4.6%	8%
CVS	CVS Health Corporation	4.5%	7.8%
PODD	Insulet Corporation	4.1%	29.9%
RVTY	Revvity, Inc.	3.9%	2.2%
EW	Edwards Lifesciences Corporation	3.9%	14.7%
CNC	Centene Corporation	3.7%	18.2%
MRK	Merck & Co., Inc.	3.7%	3.7%
HUM	Humana Inc.	3.6%	11.1%
IDXX	IDEXX Laboratories, Inc.	3.6%	13.3%
CELG-RI	Bristol-Myers Squibb Company Ce	3.4%	2.8%
BMY	Bristol-Myers Squibb Company	3.4%	2.8%
BAX	Baxter International Inc.	3.3%	5%
TMO	Thermo Fisher Scientific Inc.	3.2%	4.9%
GILD	Gilead Sciences, Inc.	3.2%	3%
IQV	IQVIA Holdings Inc.	3.2%	5.2%
GEHC	GE HealthCare Technologies Inc.	3.1%	5.8%
PEN	Penumbra, Inc.	3.1%	17.8%
EHC	Encompass Health Corporation	3%	9.4%
ABVX	Abivax S.A.	2.9%	-10.3%
UNH	UnitedHealth Group Incorporated	2.9%	12.2%
ISRG	Intuitive Surgical, Inc.	2.8%	22.9%
VEEV	Veeva Systems Inc.	2.6%	16%
VTRS	Viatris Inc.	2.6%	0.2%
GMED	Globus Medical, Inc.	2.6%	22.9%
JNJ	Johnson & Johnson	2.4%	6.8%
MTD	Mettler-Toledo International Inc.	2.2%	7.9%
EXAS	Exact Sciences Corporation	2.2%	20%
MCK	McKesson Corporation	2.1%	10.1%
FMS	Fresenius Medical Care AG & Co. KGaA	1.9%	2.6%
BRKR	Bruker Corporation	1.9%	-0.5%
HALO	Halozyme Therapeutics, Inc.	1.7%	22.1%
ELV	Elevance Health Inc.	1.7%	12.3%
HCA	HCA Healthcare, Inc.	1.7%	9.6%
MDT	Medtronic plc	1.7%	6.6%
ABT	Abbott Laboratories	1.6%	6.9%
ATR	AptarGroup, Inc.	1.5%	5.7%
BDX	Becton, Dickinson and Company	1.5%	8.3%
RPRX	Royalty Pharma plc	1.5%	7.9%
ABBV	AbbVie Inc.	1.3%	9.1%
DXCM	DexCom, Inc.	1.3%	21.6%
COR	Cencora, Inc.	1.2%	-2.5%
A	Agilent Technologies, Inc.	1.1%	9.4%
ILMN	Illumina, Inc.	1.1%	0.3%
SYK	Stryker Corporation	0.9%	10.2%
BSX	Boston Scientific Corporation	0.7%	20.3%
QGEN	Qiagen N.V.	0.7%	6.1%
COO	The Cooper Companies, Inc.	0.3%	4.6%
STE	STERIS plc	0.1%	9.9%
MASI	Masimo Corporation	-	-26.4%
CRL	Charles River Laboratories International, Inc.	-	-0.5%
AZN	AstraZeneca PLC	-0.1%	12%
UTHR	United Therapeutics Corporation	-0.3%	6.8%
DVA	DaVita Inc.	-0.3%	4.8%
BIO	Bio-Rad Laboratories, Inc.	-0.5%	0.5%
SNN	Smith & Nephew plc	-0.7%	9.3%
NBIX	Neurocrine Biosciences, Inc.	-0.9%	27.8%
GRFS	Grifols, S.A.	-1.1%	4%
ALC	Alcon Inc.	-1.3%	6.5%
THC	Tenet Healthcare Corporation	-1.6%	3.3%
HQY	HealthEquity, Inc.	-1.7%	7.2%
HOLX	Hologic, Inc.	-1.9%	6.2%
SOLV	Solventum Corporation	-2.2%	0.7%
NVS	Novartis AG	-2.4%	9%
AVTR	Avantor, Inc.	-2.5%	-5.3%
NVO	Novo Nordisk A/S	-2.5%	5.1%
DGX	Quest Diagnostics Incorporated	-2.5%	13.2%
ZBH	Zimmer Biomet Holdings, Inc.	-2.6%	9.7%
LH	Labcorp Holdings Inc.	-2.8%	8.6%
PHG	Koninklijke Philips N.V.	-2.9%	-1.7%
HSIC	Henry Schein, Inc.	-3.4%	5.2%
BMRN	BioMarin Pharmaceutical Inc.	-3.7%	4.1%
GSK	GSK plc	-3.8%	6.7%
TECH	Bio-Techne Corporation	-3.9%	-1%
ZTS	Zoetis Inc.	-3.9%	0.5%
ALGN	Align Technology, Inc.	-4.2%	1.8%
ICLR	ICON Public Limited Company	-4.5%	0.6%
ONC	BeOne Medicines Ltd.	-5.4%	41%
ELAN	Elanco Animal Health Incorporated	-6.3%	10.4%
BIIB	Biogen Inc.	-7%	-0.4%
TEM	Tempus AI, Inc.	-10.1%	84.7%
IONS	Ionis Pharmaceuticals, Inc.	-67.2%	17.1%
GMAB	Genmab A/S	-82%	-81.6%
ARWR	Arrowhead Pharmaceuticals, Inc.	-90.5%	轉虧為盈%
CYTK	Cytokinetics, Incorporated	-98.1%	318.1%
SMMT	Summit Therapeutics Inc.	-	-
RVMD	Revolution Medicines, Inc.	-	-
NUVL	Nuvalent, Inc.	-	-
MTSR	Metsera, Inc.	-	-

警語

1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整，需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

醫療類股